Toshifumi Inada
- Molecular Biology top 1%
- RNA and protein synthesis mechanisms 72
- RNA modifications and cancer 54
- RNA Research and Splicing 46
- Ubiquitin and proteasome pathways 11
- Genetics top 1%
- Bacterial Genetics and Biotechnology 23
- Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease 9
- Endocrinology top 5%
- Aging top 5%
-
- Enzyme Structure and Function 8
-
- Peptidase Inhibition and Analysis 7
- Co-authors
- Hiroji AibaKazushige KurohaKen IkeuchiKeiko KimataTsuyako TatematsuYoshitaka MatsuoRoland BeckmannYoshikazu Nakamura
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Toshifumi Inada
107 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 5.8k
- Genetics 1.6k
- Cell Biology 548
- Endocrinology 153
- Aging 40
Countries citing papers authored by Toshifumi Inada
This map shows the geographic impact of Toshifumi Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshifumi Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshifumi Inada more than expected).
Fields of papers citing papers by Toshifumi Inada
This network shows the impact of papers produced by Toshifumi Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshifumi Inada. The network helps show where Toshifumi Inada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshifumi Inada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 22 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 26 | |
| 7 | 2023 | 21 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 50 | |
| 10 | 2022 | 16 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 105 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 171 | |
| 17 | 2019 | 76 | |
| 18 | 2019 | 216 | |
| 19 | 2017 | 1 | |
| 20 | 2009 | 8 |
About Toshifumi Inada
Toshifumi Inada is a scholar working on Molecular Biology, Genetics and Cell Biology, having authored 113 papers that have together received 6.6k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (72 papers), RNA modifications and cancer (54 papers), RNA Research and Splicing (46 papers), Bacterial Genetics and Biotechnology (23 papers), Ubiquitin and proteasome pathways (11 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Enzyme Structure and Function (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Molecular Biology (5.8k citations), Genetics (1.6k citations) and Cell Biology (548 citations). Toshifumi Inada has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hiroji Aiba, Kazushige Kuroha, Ken Ikeuchi, Keiko Kimata, Tsuyako Tatematsu, Yoshitaka Matsuo, Roland Beckmann, Yoshikazu Nakamura, Teppei Morita and Lyudmila Dimitrova-Paternoga.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.